Status:
COMPLETED
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Lead Sponsor:
Goethe University
Collaborating Sponsors:
Deutsche Krebshilfe e.V., Bonn (Germany)
Conditions:
Adult Acute Lymphocytic Leukemia
Eligibility:
All Genders
15-65 years
Phase:
PHASE4
Brief Summary
The study evaluates the efficacy and tolerability of a risk- and subtype-adapted chemotherapy over one year, followed by randomized either intensified or conventional maintenance therapy. It includes ...
Eligibility Criteria
Inclusion
- Acute Lymphocytic Leukemia
- Age 15 - 65 years
Exclusion
- Serious secondary diseases which may compromise intensified chemotherapeutical treatment
- Serious psychiatric diseases, which may compromise compliance with therapy
- HIV-1 or HIV-2 Infection
- Pretreatment \> 2 weeks or chemotherapy other than Vincristine and Steroids
- Patients without central diagnosis who cannot be allocated to a risk group
Key Trial Info
Start Date :
April 1 1993
Trial Type :
INTERVENTIONAL
End Date :
May 1 2001
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT00199069
Start Date
April 1 1993
End Date
May 1 2001
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Medical Dept. II
Frankfurt, Germany